Spots Global Cancer Trial Database for sulindac
Every month we try and update this database with for sulindac cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer | NCT00039520 | Breast Cancer | docetaxel sulindac | 18 Years - | Fox Chase Cancer Center | |
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers | NCT00343629 | Unspecified Adu... | sulindac pharmacological... | 40 Years - | National Cancer Institute (NCI) | |
Urinary Biomarker Study With Sulindac and Difluoromethylornithine | NCT01636128 | Focus of Study:... | difluoromethylo... Sulindac | 40 Years - 65 Years | Cancer Prevention Pharmaceuticals, Inc. | |
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients | NCT01187901 | Adenomatous Pol... | Erlotinib Sulindac Placebo A Placebo B | 18 Years - 69 Years | University of Utah | |
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers | NCT00343629 | Unspecified Adu... | sulindac pharmacological... | 40 Years - | National Cancer Institute (NCI) | |
Sulindac for Patients With AML | NCT01843179 | Acute Myeloid L... | Cytarabine Sulindac | 60 Years - | Massachusetts General Hospital | |
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma | NCT00841204 | Precancerous Co... | sulindac placebo laboratory biom... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia | NCT00335504 | Colon Cancer Precancerous Co... Rectal Cancer | oligofructose-e... sulindac placebo atorvastatin ca... laboratory biom... | 40 Years - | National Cancer Institute (NCI) | |
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients | NCT01187901 | Adenomatous Pol... | Erlotinib Sulindac Placebo A Placebo B | 18 Years - 69 Years | University of Utah | |
Sulindac Capsules Compared With Sulindac Tablets in Healthy Volunteers | NCT00343629 | Unspecified Adu... | sulindac pharmacological... | 40 Years - | National Cancer Institute (NCI) | |
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma | NCT00841204 | Precancerous Co... | sulindac placebo laboratory biom... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma | NCT00841204 | Precancerous Co... | sulindac placebo laboratory biom... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer | NCT01856322 | Colorectal Canc... Liver Metastasi... Colorectal Aden... | Sulindac Placebo Validate assays... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Sulindac for Patients With AML | NCT01843179 | Acute Myeloid L... | Cytarabine Sulindac | 60 Years - | Massachusetts General Hospital | |
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients | NCT01187901 | Adenomatous Pol... | Erlotinib Sulindac Placebo A Placebo B | 18 Years - 69 Years | University of Utah | |
NSAID Effects on Clinical and Imaging Breast Biomarkers | NCT01761877 | Inflammation Cancer Pain Hypertension | Sulindac | - 75 Years | Stony Brook University | |
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) | NCT01483144 | Familial Adenom... | Eflornithine Eflornithine Pl... Sulindac 150 MG Sulindac placeb... | 18 Years - | Cancer Prevention Pharmaceuticals, Inc. | |
Sulindac and Epirubicin in Treating Patients With Metastatic Malignant Melanoma | NCT00755976 | Melanoma (Skin) | epirubicin hydr... sulindac immunologic tec... | 18 Years - | Cancer Trials Ireland | |
Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps | NCT00118365 | Precancerous Co... | placebo eflornithine sulindac laboratory biom... | 40 Years - 80 Years | National Cancer Institute (NCI) | |
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer | NCT01856322 | Colorectal Canc... Liver Metastasi... Colorectal Aden... | Sulindac Placebo Validate assays... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Bevacizumab/Tarceva and Tarceva/Sulindac in Squamous Cell Carcinoma of the Head and Neck | NCT00392665 | Squamous Cell C... | Bevacizumab erlotinib Sulindac | 18 Years - | Massachusetts General Hospital | |
Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma | NCT00841204 | Precancerous Co... | sulindac placebo laboratory biom... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor | NCT00068419 | Desmoid Tumor | tamoxifen citra... sulindac laboratory biom... | - 18 Years | Children's Oncology Group | |
Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor | NCT00068419 | Desmoid Tumor | tamoxifen citra... sulindac laboratory biom... | - 18 Years | Children's Oncology Group | |
Trial of Eflornithine Plus Sulindac in Patients With Familial Adenomatous Polyposis (FAP) | NCT01483144 | Familial Adenom... | Eflornithine Eflornithine Pl... Sulindac 150 MG Sulindac placeb... | 18 Years - | Cancer Prevention Pharmaceuticals, Inc. | |
Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia | NCT00368927 | Precancerous Co... Stage I Non-sma... Tobacco Use Dis... | sulindac placebo | 40 Years - 79 Years | National Cancer Institute (NCI) | |
Surgery Plus Sulindac or Surgery Alone for Advanced Colorectal Cancer | NCT01856322 | Colorectal Canc... Liver Metastasi... Colorectal Aden... | Sulindac Placebo Validate assays... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Comparison of Sulindac, Aspirin, and Ursodiol in Preventing Colorectal Cancer | NCT00062023 | Colorectal Canc... | Acetylsalicylic... Sulindac Ursodiol Sulindac Placeb... | 40 Years - 80 Years | M.D. Anderson Cancer Center |